DHX · Class II · 21 CFR 866.6010

FDA Product Code DHX: System, Test, Carcinoembryonic Antigen

Leading manufacturers include Beckman Coulter, Inc. and Ortho-Clinical Diagnostics.

28
Total
28
Cleared
119d
Avg days
1980
Since
Declining activity - 0 submissions in the last 2 years vs 2 in the prior period

FDA 510(k) Cleared System, Test, Carcinoembryonic Antigen Devices (Product Code DHX)

28 devices
1–24 of 28

About Product Code DHX - Regulatory Context

510(k) Submission Activity

28 total 510(k) submissions under product code DHX since 1980, with 28 receiving FDA clearance (average review time: 119 days).

Submission volume has declined in recent years - 0 submissions in the last 24 months compared to 2 in the prior period.

DHX devices are reviewed by the Immunology panel. Browse all Immunology devices →